Curie Manavata Cancer Centre

Nashik, Maharashtra 422101

0 studies enrolling now · 7 studies all time

What they study most

Advanced Refractory Solid Tumors, Breast Cancer, Extensive-stage Small Cell Lung Cancer, Follicular Lymphoma, Kidney Neoplasms, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma, Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion, Stage IV Non-small Cell Lung Cancer, Unresectable Soft Tissue Sarcoma

Studies at this site

• Preliminary Efficacy and Safety of INNO-206 Compared to Doxorubicin in Advanced Soft Tissue Sarcoma — Completed
• Axitinib (AG-013736) For the Treatment of Metastatic Renal Cell Cancer — Completed
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed
• Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer — Completed
• A Phase I/II Study of Carboplatin and Etoposide With or Without Obatoclax in Extensive-stage Small Cell Lung Cancer (ES-SCLC) — Completed
• Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors — Paused
• First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer — Stopped early